Avapritinib for Systemic Mastocytosis.
2021
Systemic mastocytosis (SM) is a rare myeloid neoplasm driven in ≈95% of cases by activating KIT mutations, usually D816V. SM can be indolent (ISM), smoldering (SSM) and advanced (AdvSM), the latter...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
73
References
1
Citations
NaN
KQI